Cancer of the Vagina - Diagnosis
QCGC Menu Site Map About Search

Menu
Fact Sheet
General
Diagnosis
Treatment
Anaesthetics
Chaplaincy
Chemotherapy
Dietetics
Lymphoedema
Nursing
OT
Pharmacy
Physiotherapy
Psychology
Radiotherapy
Social Work

 

Contents

bulletWork-up for suspected Vaginal malignancy
bulletDiagnosis
bulletRoutine preoperative investigations 
bulletScreening

Work-up for a suspected Vaginal Malignancy

Signs for Suspected Vaginal Malignancy:

bulletPainless vaginal bleeding
bulletLower abdominal pain

Diagnosis 

A gynaecological examination and inspection of the vagina can perform the diagnosis. However, vaginal carcinoma is sometimes missed on gynaecological examination because the lesion is either small or it is situated in the lower parts of the vagina and the blades of the speculum cover the lesion during the examination. A vaginal biopsy must be performed to prove diagnosis. When indicated, an examination under anaesthetic and cystoscopy/proctoscopy should be performed to exclude bladder or rectal involvement. 

For patients with abnormal PAP smears and no gross abnormality, a Colposcopy/Vaginoscopy (staining with acidic acid &/or Lugol's iodine) with a careful examination of the vagina should be performed. 

Any suspicious vaginal lesion should be biopsied. 

Routine preoperative investigations 

bulletFull blood count
bulletSerum creatinine and electrolytes
bulletLiver function tests
bulletBlood sugar
bulletUrinalysis
bulletElectrocardiogram
bulletChest x-ray

For all patients a CT-scan of the abdomen and the pelvis might be warranted in order to determine status of the primary tumour, liver, kidneys and the retroperitoneal lymph nodes

Screening

The incidence of vaginal cancer is 0.6 out of 100,000. Because the disease is so rare, there is no accepted method for screening for vaginal cancer. 

Some authors recommend regular examinations for women showing the following conditions: 

  1. Vaginal Intraepithelial Neoplasia (VAIN)
  2. Women who had pre-invasive (CIN III) or invasive cervical carcinoma before. Thirty percent of patients with vaginal cancer have a history of either CIN III or cervical cancer. 

Dr Andreas Obermair, MD
Associate Professor of Gynecology and Obstetrics,
University of Vienna
Clinical Fellow, Gynaecologic Oncology,Queensland Centre for Gynaecological Cancer.

 

 

Email us

Feedback

Online Support Group

Community Support

Web Links

Technical Support

Sponsors

GCS

 

 
© GCS Inc. Last revised Sunday, 30 September 2001.
Contact Prof A J Crandon. Webmaster services palmer.net.au